HealthPhoto: FirstpostBharat Biotech Cuts Malaria Vaccine Price by 40% After UNICEF-Gavi Deal
Bharat Biotech has agreed with Gavi and UNICEF to reduce the price of the malaria vaccine RTS,S/AS01 by about 40%, lowering it to 5.50 euros per dose from early 2027. This deal is expected to save $50 million for child immunisation programs and protect up to one million additional children between 2027 and 2029. The vaccine was the first malaria vaccine recommended by WHO in 2021.
Firstpost·




